➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Dow
McKesson
Johnson and Johnson
Express Scripts
Medtronic

Last Updated: September 27, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 210318


Email this page to a colleague

« Back to Dashboard

NDA 210318 describes ASPIRIN AND DIPYRIDAMOLE, which is a drug marketed by Amneal Pharms, Ani Pharms, Barr, Dr Reddys, Glenmark Pharms Sa, Lannett Co Inc, Micro Labs, Par Pharm Inc, Sandoz Inc, Sun Pharm, and Zydus Pharms, and is included in eleven NDAs. It is available from thirteen suppliers. Additional details are available on the ASPIRIN AND DIPYRIDAMOLE profile page.

The generic ingredient in ASPIRIN AND DIPYRIDAMOLE is aspirin; dipyridamole. There are twenty-two drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the aspirin; dipyridamole profile page.
Summary for 210318
Tradename:ASPIRIN AND DIPYRIDAMOLE
Applicant:Glenmark Pharms Sa
Ingredient:aspirin; dipyridamole
Patents:0
Pharmacology for NDA: 210318
Suppliers and Packaging for NDA: 210318
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ASPIRIN AND DIPYRIDAMOLE aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 210318 ANDA Glenmark Pharmaceuticals Inc., USA 68462-405 68462-405-30 30 CAPSULE in 1 BOTTLE (68462-405-30)
ASPIRIN AND DIPYRIDAMOLE aspirin; dipyridamole CAPSULE, EXTENDED RELEASE;ORAL 210318 ANDA Glenmark Pharmaceuticals Inc., USA 68462-405 68462-405-60 60 CAPSULE in 1 BOTTLE (68462-405-60)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength25MG;200MG
Approval Date:May 24, 2019TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Moodys
Mallinckrodt
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.